Cefminox
Cefminox Basic information
- Product Name:
- Cefminox
- Synonyms:
-
- (6r-(6-alpha,7-alpha))-7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt
- (6r,7s)-7-(2-(((s)-2-amino-2-carboxyethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- CEFMINOX SOUDIUM
- 7-[[2-[(2-amino-2-carboxyethyl)thio]-1-oxoethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(2-amino-2-carboxyethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt, [6R-[6α,7α,7(S*)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[[(2S)-2-amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt, (6R,7S)-
- Cefminox sodium salt
- Meicelin
- CAS:
- 75481-73-1
- MF:
- C16H21N7O7S3
- MW:
- 519.58
- Mol File:
- 75481-73-1.mol
Cefminox Chemical Properties
- CAS DataBase Reference
- 75481-73-1(CAS DataBase Reference)
Cefminox Usage And Synthesis
Application
It is mainly used for sepsis, tonsillitis, bronchitis, pneumonia, lung abscess, pyelonephritis, cystitis, cholecystitis, peritonitis, pelvic inflammatory disease, adnexitis, endometritis, and postoperative infections caused by sensitive bacteria.
Definition
ChEBI: Cefminox is a second-generation cephamycin antibiotic having [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl and 2-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}acetamido side-groups located respectively at positions 3 and 7beta of the cephem nucleus. A broad-spectrum bactericide, it is especially effective against Gram-negative and anaerobic bacteria. It is a cephamycin and a member of tetrazoles. It is a conjugate acid of a cefminox(1-).
Antimicrobial activity
A semisynthetic cephamycin. Activity is similar to that of
cefoxitin and cefotetan, but the activity against enterobacteria
and B. fragilis is somewhat better . C. difficile
is inhibited by 4–16 mg/L. It is stable to the common
β-lactamases of enterobacteria and Bacteroides spp.
A 15-min intravenous infusion of 1 g achieves a serum concentration
of 30 mg/L after 1 h. The plasma half-life is c. 2 h
and around 68% is protein bound.
Its safety profile and uses are similar to those of other
cephamycins. It is available in Japan.
CefminoxSupplier
- Tel
- 021-50182298 021-50180596
- sales@boylechem.com
- Tel
- 15527768836
- 1791901229@qq.com
- Tel
- 0571-82693216
- info@yuhaochemical.com
- Tel
- 010-56205725
- waley188@sohu.com
- Tel
- 025-57798810
- sales@sunlidabio.com
Cefminox(75481-73-1)Related Product Information
- Glycine
- 2-Methoxyethanol
- ALTRENOGEST
- Acetaminophen
- Ceftriaxone sodium
- Oxygen
- 7-TMCA
- (6R-(6-alpha,7-alpha))-7-((((2-Amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt
- 1-METHYL-3-AZETIDINOL
- 3-METHOXY-AZETIDINE
- ACETAMINOPHENOL BP/USP
- AMINO ACIDS
- Cefminox
- 1H-Tetrazole, 5-((3-(ethylthio)propyl)thio)-1-methyl-
- Methoxy
- CEFMINOXSODIUM